Market revenue in 2023 | USD 4,158.0 million |
Market revenue in 2030 | USD 5,262.6 million |
Growth rate | 3.4% (CAGR from 2023 to 2030) |
Largest segment | Azoles |
Fastest growing segment | Echinocandins |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Azoles, Echinocandins, Polyenes, Allylamines |
Key market players worldwide | Novartis AG ADR, Pfizer Inc, Bayer AG, Sanofi SA, Merck KGaA, Merck & Co Inc, GlaxoSmithKline, Abbott Laboratories, Enzon Pharmaceuticals Inc, Astellas Pharma Inc, Glenmark Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account